Status:
TERMINATED
Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo
Lead Sponsor:
Henry Ford Health System
Conditions:
Generalized Vitiligo
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
As part of this study, you may have a procedure called phototherapy which involves either VL-UVA or NB-UVB irradiation. NB-UVB phototherapy is not experimental in vitiligo, but use of VL-UVA1 photothe...
Eligibility Criteria
Inclusion
- Subjects ≥ 18 years of age with a diagnosis of generalized vitiligo
- Subjects on a stable topical/oral regimen for the past 3 months and continuing on a stable regimen
- Subjects able to understand the requirements of the study
- Subjects able and willing to sign informed consent
Exclusion
- Subjects on photosensitizing medications
- Subjects receiving any concurrent phototherapy
- Subjects who plan to use tanning parlors or expose themselves to excess sunlight
- Subjects with known photosensitivity disorder
- Subjects with apparent phototoxicity
- Subjects with unstable vitiligo
- Subjects currently using bleaching agents
- Subjects who are pregnant, lactating, or planning on becoming pregnant
- Subjects who in the opinion of the investigator/sub-investigator, are not appropriate candidates for this study
Key Trial Info
Start Date :
February 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 2 2020
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT05238077
Start Date
February 26 2018
End Date
June 2 2020
Last Update
February 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard,
Detroit, Michigan, United States, 48202